The Institute of Cancer Research (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "The Institute of Cancer Research" in English language version.

refsWebsite

Global rank English rank

17icr.ac.uk

low place

15web.archive.org

1^st place

9nih.gov

4^th place

8doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1hesa.ac.uk

6,440^th place

5,212^th place

1london.ac.uk

low place

1independent.co.uk

36^th place

33^rd place

1timeshighereducation.com

1,554^th place

1,109^th place

1royalsoced.org.uk

low place

7,521^st place

1acs.org

1,248^th place

1,104^th place

1platinummetalsreview.com

low place

1worldcat.org

5^th place

1esmo.org

low place

1fda.gov

447^th place

338^th place

acs.org

pubs.acs.org

"Collaboration Yielded A New Class of Cancer Drugs". Chemical and Engineering News. Retrieved 12 October 2011.

doi.org

Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.
Connor, F; Smith, A; Wooster, R; Stratton, M; Dixon, A; Campbell, E; Tait, T. M.; Freeman, T; Ashworth, A (1997). "Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene". Human Molecular Genetics. 6 (2): 291–300. doi:10.1093/hmg/6.2.291. PMID 9063750.
Bignell, G; Micklem, G; Stratton, M. R.; Ashworth, A; Wooster, R (1997). "The BRC repeats are conserved in mammalian BRCA2 proteins". Human Molecular Genetics. 6 (1): 53–8. doi:10.1093/hmg/6.1.53. PMID 9002670.
Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian (14 April 2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy". Nature. 434 (7035): 917–921. Bibcode:2005Natur.434..917F. doi:10.1038/nature03445. ISSN 1476-4687. PMID 15829967. S2CID 4364706.
Fong, P. C.; Boss, D. S.; Yap, T. A.; Tutt, A; Wu, P; Mergui-Roelvink, M; Mortimer, P; Swaisland, H; Lau, A; O'Connor, M. J.; Ashworth, A; Carmichael, J; Kaye, S. B.; Schellens, J. H.; De Bono, J. S. (2009). "Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers". New England Journal of Medicine. 361 (2): 123–34. doi:10.1056/NEJMoa0900212. PMID 19553641. S2CID 10051747.
Dhomen, N; Reis-Filho, J. S.; Da Rocha Dias, S; Hayward, R; Savage, K; Delmas, V; Larue, L; Pritchard, C; Marais, R (2009). "Oncogenic Braf induces melanocyte senescence and melanoma in mice". Cancer Cell. 15 (4): 294–303. doi:10.1016/j.ccr.2009.02.022. PMID 19345328.

esmo.org

"View - European Society for Medical Oncology (ESMO)". 22 July 2011. Archived from the original on 22 July 2011.

fda.gov

[2] Archived 17 June 2011 at the Wayback Machine

harvard.edu

ui.adsabs.harvard.edu

Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian (14 April 2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy". Nature. 434 (7035): 917–921. Bibcode:2005Natur.434..917F. doi:10.1038/nature03445. ISSN 1476-4687. PMID 15829967. S2CID 4364706.

hesa.ac.uk

"Where do HE students study?". Higher Education Statistics Agency. Students by HE provider: HE student enrolments by HE provider. Retrieved 3 April 2025.

icr.ac.uk

"The Institute of Cancer Research Annual Report and Financial Statements 2011" (PDF). Institute of Cancer Research. Archived from the original (PDF) on 24 September 2015. Retrieved 13 April 2012.
"Financial Statements for the Year to 31 July 2023" (PDF). Institute of Cancer Research. Retrieved 21 January 2024.
"ICR announces new Chair of Board of Trustees". Archived from the original on 16 January 2014. Retrieved 14 December 2021.
"ICR announces appointment of new Chief Executive". Retrieved 14 December 2021.
"Annual Review 2009" (PDF). Institute of Cancer Research. Archived from the original (PDF) on 24 November 2010. Retrieved 21 October 2010.
"Long-term Achievements". Institute of Cancer Research. Archived from the original on 24 November 2010. Retrieved 23 February 2011.
"ICR rated second in UK among all higher education institutions in REF 2021 analysis". Institute of Cancer Research. Retrieved 12 May 2022.
"Our appeals and campaigns". Institute of Cancer Research. Retrieved 18 February 2016.
"The Centre for Molecular Pathology is opened". Icr.ac.uk. Archived from the original on 22 March 2014. Retrieved 20 November 2012.
"New Centre for Cancer Imaging to open window onto cancer - The Institute of Cancer Research, London". www.icr.ac.uk.
"Scientific Strategy". Icr.ac.uk. Archived from the original on 15 May 2011. Retrieved 23 February 2011.
"New Drug Targeting Cancer Weakness Shows Great Promise". Icr.ac.uk. 25 June 2009. Archived from the original on 28 June 2009. Retrieved 29 April 2010.
"Scientists Unravel Crucial Skin Cancer Switch". Icr.ac.uk. Archived from the original on 25 November 2010. Retrieved 29 April 2010.
[1] Archived 29 December 2010 at the Wayback Machine
"New Drug Blocks Common Cancer Pathway". Icr.ac.uk. 15 July 2009. Archived from the original on 26 July 2009. Retrieved 29 April 2010.
"Prostate Cancer Drug Abiraterone Shows Impressive New Research Results". Archived from the original on 19 February 2014. Retrieved 16 July 2015.

ieu.icr.ac.uk

"Drug discoveries raise profile of cancer chemotherapy". The Institute of Cancer Research's Interactive Education Unit. Archived from the original on 27 January 2012. Retrieved 12 October 2011.

independent.co.uk

"Britain's best hospitals: A patients' guide". The Independent. 20 March 2008. Retrieved 20 October 2010.

london.ac.uk

"Ordinance 9: Member institutions of the University" (PDF). Lon.ac.uk. 29 March 2010. Retrieved 20 May 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.
Connor, F; Smith, A; Wooster, R; Stratton, M; Dixon, A; Campbell, E; Tait, T. M.; Freeman, T; Ashworth, A (1997). "Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene". Human Molecular Genetics. 6 (2): 291–300. doi:10.1093/hmg/6.2.291. PMID 9063750.
Bignell, G; Micklem, G; Stratton, M. R.; Ashworth, A; Wooster, R (1997). "The BRC repeats are conserved in mammalian BRCA2 proteins". Human Molecular Genetics. 6 (1): 53–8. doi:10.1093/hmg/6.1.53. PMID 9002670.
Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian (14 April 2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy". Nature. 434 (7035): 917–921. Bibcode:2005Natur.434..917F. doi:10.1038/nature03445. ISSN 1476-4687. PMID 15829967. S2CID 4364706.
Fong, P. C.; Boss, D. S.; Yap, T. A.; Tutt, A; Wu, P; Mergui-Roelvink, M; Mortimer, P; Swaisland, H; Lau, A; O'Connor, M. J.; Ashworth, A; Carmichael, J; Kaye, S. B.; Schellens, J. H.; De Bono, J. S. (2009). "Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers". New England Journal of Medicine. 361 (2): 123–34. doi:10.1056/NEJMoa0900212. PMID 19553641. S2CID 10051747.
Dhomen, N; Reis-Filho, J. S.; Da Rocha Dias, S; Hayward, R; Savage, K; Delmas, V; Larue, L; Pritchard, C; Marais, R (2009). "Oncogenic Braf induces melanocyte senescence and melanoma in mice". Cancer Cell. 15 (4): 294–303. doi:10.1016/j.ccr.2009.02.022. PMID 19345328.

ncbi.nlm.nih.gov

Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.

platinummetalsreview.com

"Scientific Symposium on Paraplatin" (PDF). Platinum metals review. Retrieved 12 October 2011.

royalsoced.org.uk

Biographical Index of Former Fellows of the Royal Society of Edinburgh 1783–2002 (PDF). The Royal Society of Edinburgh. July 2006. ISBN 0-902-198-84-X. Archived from the original (PDF) on 24 January 2013. Retrieved 21 August 2016.

semanticscholar.org

api.semanticscholar.org

Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian (14 April 2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy". Nature. 434 (7035): 917–921. Bibcode:2005Natur.434..917F. doi:10.1038/nature03445. ISSN 1476-4687. PMID 15829967. S2CID 4364706.
Fong, P. C.; Boss, D. S.; Yap, T. A.; Tutt, A; Wu, P; Mergui-Roelvink, M; Mortimer, P; Swaisland, H; Lau, A; O'Connor, M. J.; Ashworth, A; Carmichael, J; Kaye, S. B.; Schellens, J. H.; De Bono, J. S. (2009). "Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers". New England Journal of Medicine. 361 (2): 123–34. doi:10.1056/NEJMoa0900212. PMID 19553641. S2CID 10051747.

timeshighereducation.com

"REF 2021: Quality ratings hit new high in expanded assessment". Times Higher Education. 12 May 2022.

web.archive.org

"The Institute of Cancer Research Annual Report and Financial Statements 2011" (PDF). Institute of Cancer Research. Archived from the original (PDF) on 24 September 2015. Retrieved 13 April 2012.
"ICR announces new Chair of Board of Trustees". Archived from the original on 16 January 2014. Retrieved 14 December 2021.
"Annual Review 2009" (PDF). Institute of Cancer Research. Archived from the original (PDF) on 24 November 2010. Retrieved 21 October 2010.
"Long-term Achievements". Institute of Cancer Research. Archived from the original on 24 November 2010. Retrieved 23 February 2011.
"The Centre for Molecular Pathology is opened". Icr.ac.uk. Archived from the original on 22 March 2014. Retrieved 20 November 2012.
"Scientific Strategy". Icr.ac.uk. Archived from the original on 15 May 2011. Retrieved 23 February 2011.
Biographical Index of Former Fellows of the Royal Society of Edinburgh 1783–2002 (PDF). The Royal Society of Edinburgh. July 2006. ISBN 0-902-198-84-X. Archived from the original (PDF) on 24 January 2013. Retrieved 21 August 2016.
"Drug discoveries raise profile of cancer chemotherapy". The Institute of Cancer Research's Interactive Education Unit. Archived from the original on 27 January 2012. Retrieved 12 October 2011.
"New Drug Targeting Cancer Weakness Shows Great Promise". Icr.ac.uk. 25 June 2009. Archived from the original on 28 June 2009. Retrieved 29 April 2010.
"Scientists Unravel Crucial Skin Cancer Switch". Icr.ac.uk. Archived from the original on 25 November 2010. Retrieved 29 April 2010.
[1] Archived 29 December 2010 at the Wayback Machine
"New Drug Blocks Common Cancer Pathway". Icr.ac.uk. 15 July 2009. Archived from the original on 26 July 2009. Retrieved 29 April 2010.
"Prostate Cancer Drug Abiraterone Shows Impressive New Research Results". Archived from the original on 19 February 2014. Retrieved 16 July 2015.
"View - European Society for Medical Oncology (ESMO)". 22 July 2011. Archived from the original on 22 July 2011.
[2] Archived 17 June 2011 at the Wayback Machine

worldcat.org

search.worldcat.org

Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian (14 April 2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy". Nature. 434 (7035): 917–921. Bibcode:2005Natur.434..917F. doi:10.1038/nature03445. ISSN 1476-4687. PMID 15829967. S2CID 4364706.